Producción Científica

El Grupo Médica Sur tiene el honor de contar con varios investigadores que pertenecen al Sistema Nacional de Investigadores (SNI) del Consejo Nacional de Ciencia y Tecnología (CONACyT) y que reciben un apoyo económico por parte de la Fundación Clínica Médica Sur:

• Misael Uribe Esquivel, Nivel Emérito
• Jorge Albores Saavedra, Nivel III
• Norberto Carlos Chávez Tapia, Nivel II
• Désirée Erlinda Larenas Linneman, Nivel II
• María Adela Poitevin Chacón, Nivel II
• Nancy Edith Aguilar Olivos, Nivel I
• Varenka J. Barbero Becerra, Nivel I
• Rita Dorantes Heredia, Nivel I
• Eduardo González Pier, Nivel I
• Daniel Motola Kuba, Nivel I
• Natalia Nuño Lambarri, Nivel I
• José Manuel Ruiz Morales, Candidato

Gracias a la labor de estos investigadores en el segundo trimestre de 2019 se logró la publicación de 4 artículos, 3 en revistas nacionales y 1 en revista internacional.

Publicaciones 2019

• Pali-Schöll I, Meinlschmidt P, Larenas-Linnemann D, Purschke B, Hofstetter G, Rodríguez-Monroy FA, et.al. Edible insects: Cross-recognition of IgE from crustacean- and house dust mite allergic patients, and reduction of allergenicity by food processing. World Allergy Organization Journal. 2019 Jan 26;12(1):100006. doi: 10.1016/j.waojou.2018.10.001
  https://www.ncbi.nlm.nih.gov/pubmed/30937131
• Chavannes NH, Reitsma S, Cruz AA, da Silva J, Serpa FS, Larenas-Linnemann D, et.al. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma. Clinical and Translational Allergy. 2019 Mar 11;9:16. doi: 10.1186/s13601-019-0252-0.
  https://www.ncbi.nlm.nih.gov/pubmed/30911372
• Panopoulou G, Gonzalez-Pier E. Challenges in HIV infection control in transgender women sex workers. The Lancet Public Health. 2019 Mar;4(3):e117-e118. doi: 10.1016/S2468-2667(18)30259-7.
  https://www.ncbi.nlm.nih.gov/pubmed/30683586
• Dávila-Dupont D, Motola-Kuba D, Dorantes-Heredia R, González-Alonso BK, Alcántara-Velarde T, García-Santisteban R, Martínez-Sámano JE, Grimaldo-Roque HJ, Ruiz-Morales JM. Risk of Pneumonitis with the Use of Different Immune Checkpoint Inhibitors in a Mexican Population. Oncology. 2019;96(5):268-272. doi: 10.1159/000497405.
  https://www.ncbi.nlm.nih.gov/pubmed/30861515
• Dorantes-Heredia R, Motola-Kuba D, Murphy-Sanchez C, Izquierdo-Tolosa CD, Ruiz-Morales JM. Spontaneous regression as a 'burned-out' non-seminomatous testicular germ cell tumor: a case report and literature review. Journal of Surgical Case Reports.  2019 Jan 9;2019(1):rjy358. doi: 10.1093/jscr/rjy358.
  https://www.ncbi.nlm.nih.gov/pubmed/30647899
• Bernal-Reyes R, Castro-Narro G, Malé-Velázquez R, Carmona-Sánchez R, González-Huezo MS, García-Juárez I, Chávez-Tapia N, et al. The Mexican consensus on nonalcoholic fatty liver disease. Revista de Gastroenterología de México 2019 Jan - Mar;84(1):69-99. doi: 10.1016/j.rgmx.2018.11.007.
  https://www.ncbi.nlm.nih.gov/pubmed/30711302
• Devillier P, De Vries G, Keil T, Sheikh A, Orlando V, Larenas-Linnemann D. et al. Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study. Clinical & Experimental Allergy. 2019 Apr;49(4):442-460.
  doi: 10.1111/cea.13333.
  https://www.ncbi.nlm.nih.gov/pubmed/30597673
• Larenas-Linnemann D, Mullol J, Ivancevich JC, Anto JM, Cardona V, Dedeu T, et al. MASK (Mobile Airways Sentinel Network), a mobile App with ARIA's comprehensive solution in Spanish-speaking countries.Revista Alergia México. 2019;66(2):263-268. doi:10.29262/ram.v66i2.628
  https://www.ncbi.nlm.nih.gov/pubmed/31200425
• Larenas-Linnemann D, Luna-Pech JA, Rodríguez-Pérez N, Rodríguez-González M, Arias-Cruz A, Blandón-Vijil MV, et al. GUIMIT 2019, Mexican Guideline on Immunotherapy. Guideline on the diagnosis of IgE-mediated allergic disease and immunotherapy following the ADAPTE approach.  Revista Alergia México. 66 Suppl 1:1-105. doi: 10.29262/ram.v66i5.631.
  https://www.ncbi.nlm.nih.gov/pubmed/31200597
• López-Sánchez GN, Dóminguez-Pérez M, Uribe M, Nuño-Lámbarri N. The fibrogenic process and the unleashing of acute-on-chronic liver failure. Clinical and Molecular Hepatology. 2019:14. doi: 10.3350/cmh.2019.0011.
  https://www.ncbi.nlm.nih.gov/pubmed/31195778
• Solsona-Vilarrasa E, Fucho R, Torres S, Nuñez S, Nuño-Lámbarri N, Enrich C, García-Ruiz C, Fernández-Checa JC. Cholesterol enrichment in liver mitochondria impairs oxidative phosphorylation and disrupts the assembly of respiratory supercomplexes.Redox Biology. 2019 Jun;24:101214.  doi: 10.1016/j.redox.2019.101214.   
  https://www.ncbi.nlm.nih.gov/pubmed/31108462
• Domínguez-Pérez M, Simoni-Nieves A, Rosales P, Nuño-Lámbarri N, Rosas-Lemus M, Souza V, et al. Cholesterol burden in the liver induces mitochondrial dynamic changes and resistance to apoptosis. Journal of Cellular Physiology. 2019;234(5):7213-7223. Doi:10.1002/jcp.27474
  https://www.ncbi.nlm.nih.gov/pubmed/30239004